BiologicalDrug
Darvadstrocel clinical trials
Also written Cx601.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses darvadstrocel is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal FistulaTerminatedPhase 4TakedaNCT04118088Written as Darvadstrocel
- A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's DiseaseTerminatedPhase 3TakedaNCT04701411Written as Darvadstrocel
- Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaCompletedPhase 3TakedaNCT04075825Written as Darvadstrocel
- Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)CompletedPhase 3Tigenix S.A.U.NCT03279081Written as Cx601
- Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's DiseaseCompletedPhase 3TakedaNCT03706456Written as Darvadstrocel
- Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.CompletedPhase 1/2Tigenix S.A.U.NCT01372969Written as Cx601
Codes
What other systems call darvadstrocel · ClinicalTrials.gg INT014572
- UNII (FDA) 31W7R94KYTDARVADSTROCELOne source FDA
- NCI Thesaurus C171654DarvadstrocelOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 31W7R94KYT | DARVADSTROCEL | One source FDA |
| NCI Thesaurus | C171654 | Darvadstrocel | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.